IGF-1 LR3

Recombinant Versus Synthetic: Two Different Quality Problems

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Synthetic peptides are built stepwise and their characteristic impurities are deletion sequences (chains missing a residue). Recombinant proteins are expressed in living cells and their characteristic impurities are host cell proteins, host DNA, endotoxin and misfolded isomers. These require entirely different testing.

Key facts

Synthetic route
Solid-phase, stepwise coupling
Synthetic impurities
Deletion sequences, truncations
Recombinant route
Expression in host cells
Recombinant impurities
Host protein, DNA, endotoxin
Also possible
Misfolded disulfide isomers
IGF-1 LR3 route
Recombinant

How a synthetic peptide fails

Solid-phase synthesis adds one residue at a time, and each coupling is slightly less than complete. The failures accumulate as deletion sequences, chains identical to the target but missing a residue. At 99% efficiency per step a 39-residue peptide finishes around 68% full-length. These impurities differ from the target by one residue's mass and are detectable by mass spectrometry.

How a recombinant protein fails

Living cells build the protein correctly or not at all. There are no deletion sequences, because ribosomal synthesis does not partially fail that way. What contaminates the product instead is everything else the host cell contained: its own proteins, its DNA, and in bacterial systems endotoxin from the cell wall. Purification removes most but never all.

Research material referenced

IGF-1 LR3 1mg, third-party HPLC tested

Buy IGF-1 LR3 · £49.99

Why endotoxin is its own category

Endotoxin is a bacterial cell wall component that provokes strong biological responses at very low concentrations. It is not a protein and does not appear in a protein purity figure at all. It requires its own assay, and for a recombinant protein expressed in bacteria it is a standard specification rather than an optional extra.

The folding problem on top

Correct amino acid sequence does not guarantee correct three-dimensional structure. For a protein with three disulfide bonds, misfolded isomers have identical mass and identical composition. They differ only in which cysteines paired with which. No purity figure and no mass spectrum distinguishes them.

What a certificate should therefore show

For a synthetic peptide: purity by HPLC, mass by MS, net peptide content, water and counter-ion content. For a recombinant protein: purity, host cell protein, host DNA, endotoxin, and ideally something addressing conformation or biological activity. A certificate for a recombinant protein that reads exactly like a synthetic peptide's is testing for the wrong failures.

The practical consequence

Reading an IGF-1 LR3 certificate with synthetic-peptide expectations means checking for problems this production route does not have, while not checking for the ones it does. It is the single most useful thing to understand about this category.

Quick reference

Synthetic peptideRecombinant protein
Built byStepwise chemistryLiving host cells
Main impurityDeletion sequencesHost protein, DNA, endotoxin
Folding riskMinimalReal (disulfide isomers)
Detectable by MSYesMisfolds are not

Frequently asked questions

Do recombinant proteins have deletion sequences?

No. Ribosomal synthesis does not partially fail that way. The protein is built correctly or not at all.

What is endotoxin and why test for it?

A bacterial cell wall component that provokes strong biological responses at low concentrations. It does not appear in a protein purity figure and needs its own assay.

Can a purity figure tell me the protein is folded correctly?

No. Misfolded disulfide isomers have identical mass and composition. Only the cysteine pairing differs.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More IGF-1 LR3 articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.